Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ALL AMERICAN GROUP INC (COHM)
|
Add to portfolio |
|
|
|
| Price: |
$0.22
| | Metrics |
| OS: |
16.2
|
M
| |
-91
|
% ROE
|
| Market cap: |
$3.56
|
M
| |
-8
|
% ROIC
|
|
Net debt:
|
$208
|
k
| |
0.0
|
x Debt/EBITDA
|
|
EV:
|
$3.77
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$9.3
|
M
| |
0.4
|
x EV/EBITDA
|
|
EBIT
|
$3.1
|
M
| |
1.2
|
x EV/EBIT
|
| EPS |
($1.69)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| Revenues | 60.6 | 119.6 | 119.2 | 159.7 | 702.4 | 802.3 | 636.9 |
| Revenue growth | -49.3% | 0.3% | -25.4% | -77.3% | -12.5% | 26.0% | |
| Cost of goods sold | 61.7 | 102.2 | 106.3 | 139.7 | 679.2 | 689.5 | 544.5 |
| Gross profit | -1.0 | 17.4 | 12.8 | 19.9 | 23.2 | 112.8 | 92.4 |
| Gross margin | -1.7% | 14.5% | 10.8% | 12.5% | 3.3% | 14.1% | 14.5% |
| Sales and marketing | 3.6 | 7.1 | 8.3 | 8.3 | 28.3 | 28.6 | 22.9 |
| General and administrative | 11.2 | 13.0 | 16.4 | 16.5 | 30.8 | 31.5 | 29.7 |
| EBIT | -0.9 | -2.7 | -11.9 | -4.9 | -35.9 | 18.7 | 11.9 |
| EBIT margin | -1.5% | -2.3% | -9.9% | -3.0% | -5.1% | 2.3% | 1.9% |
| Pre-tax income | -20.6 | -20.2 | -11.1 | 4.2 | -37.4 | 20.9 | 12.7 |
| Income taxes | -0.3 | -1.5 | -0.2 | 3.1 | -18.0 | 6.6 | 4.3 |
| Tax rate | 1.7% | 7.6% | 1.4% | 75.1% | 48.2% | 31.6% | 33.8% |
| Earnings from continuing ops | -20.2 | -18.7 | -10.9 | 1.0 | -19.4 | 14.3 | 8.4 |
| Earnings from discontinued ops | | | | | | 15.3 | 0.0 |
| Net income | -4.7 | -69.0 | -38.8 | -31.8 | -26.4 | 29.6 | 8.5 |
| Net margin | -7.8% | -57.7% | -32.5% | -19.9% | -3.8% | 3.7% | 1.3% |
| |
| Diluted EPS | ($1.26) | ($1.18) | ($0.70) | $0.07 | ($1.24) | $0.92 | $0.55 |
| Shares outstanding (diluted) | 16.1 | 15.8 | 15.7 | 15.6 | 15.6 | 15.6 | 15.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|